AI Article Synopsis

  • The study aimed to explore how frailty impacts cancer-related fatigue and quality of life in prostate cancer patients, analyzing 108 out of 254 outpatients.
  • Results showed a 63% prevalence of frailty, with older age linked to greater frailty severity but not to the levels of fatigue.
  • Patients with frailty experienced significantly higher fatigue and poorer quality of life compared to those without frailty, emphasizing the need to consider frailty in treatment decisions, especially for older patients.

Article Abstract

Objective: To investigate the prevalence of frailty and its effects on cancer-related fatigue and quality of life among patients with prostate cancer.

Methods: In this cross-sectional study, questionnaires were administered to 254 outpatients who visited the Department of Urology at Kagawa University Hospital for prostate cancer; finally, 108 outpatients were analyzed. Frailty, cancer-related fatigue and quality of life were assessed using the G8 screening tool, Japanese version of the Brief Fatigue Inventory and Japanese version of the Short Form 8 Health Survey, respectively. We defined frailty based on a score ≤14 points and divided the patients into frailty and no-frailty groups. We also compared the severity of cancer-related fatigue and quality of life between groups.

Results: The prevalence of frailty among 108 outpatients was 63%. Older age correlated with frailty severity (P = 0.0007) but not cancer-related fatigue severity (P = 0.2391). The proportion of patients on treatment or with metastasis was not significantly different between groups. The frailty group had higher cancer-related fatigue severity (P = 0.004) and decreased levels of general activity, mood, walking ability, normal work and enjoyment of life, especially on the Brief Fatigue Inventory subscale. The frailty group had lower physical and mental quality of life than the no-frailty group or general population.

Conclusions: The frailty rate for these patients increased with age, exceeding 60% regardless of the treatment status, and was associated with worsened cancer-related fatigue severity and reduced quality of life. Our study highlights the importance of assessing frailty when selecting treatment, especially in older patients.

Download full-text PDF

Source
http://dx.doi.org/10.1093/jjco/hyae015DOI Listing

Publication Analysis

Top Keywords

cancer-related fatigue
28
quality life
24
fatigue quality
16
fatigue severity
12
frailty
10
fatigue
9
frailty cancer-related
8
prostate cancer
8
cross-sectional study
8
prevalence frailty
8

Similar Publications

Effects of a comprehensive program on reducing cancer-related fatigue: A randomized controlled trial.

J Pain Symptom Manage

December 2024

West China School of Nursing, Sichuan University/West China Hospital, Sichuan University, Chengdu, China. Electronic address:

Article Synopsis
  • - The study investigates a comprehensive web-based program designed to help gastric cancer patients manage cancer-related fatigue (CRF) during chemotherapy, addressing not just fatigue but also self-efficacy, sleep quality, anxiety, depression, pain, and overall quality of life (QoL).
  • - A total of 92 patients were split into two groups, where the intervention group participated in an online program for 12 weeks with additional support, while the control group received standard care. Outcomes were measured at different time points to assess the program's effectiveness.
  • - Results showed significant improvements in CRF and associated symptoms for the intervention group, demonstrating that the web-based program effectively enhances the well-being of cancer patients, though there was no notable change in pain
View Article and Find Full Text PDF

Fufang Ejiao Syrup has shown promising clinical effectiveness and safety in treating the syndrome of Qi and blood deficiency in cancer-related fatigue. Expert consensus on clinical application of Fufang Ejiao Syrup in treating syndrome of Qi and blood deficiency in cancer-related fatigue was formulated by a panel of 33 multidisciplinary experts in Chinese and western clinical medicine, methodology, and pharmacy fields from China. They conducted a questionnaire survey among clinicians and systematically reviewed the existing literature on Fufang Ejiao Syrup.

View Article and Find Full Text PDF

A protocol for a feasibility study of Cognitive Bias Modification training (IVY) countering fatigue in people with breast cancer.

Pilot Feasibility Stud

December 2024

Centre for eHealth & Well-Being Research, Section Psychology, Health and Technology, University of Twente, Enschede, the Netherlands.

Background: Cancer-related fatigue (CRF) is the most prevalent, distressing, and quality of life disturbing symptom during and after cancer treatment for many cancer types including breast cancer. The experience and burden of this symptom can induce a cognitive bias towards fatigue or a fatigue-related self-image, which can further increase the fatigue symptoms and related behaviour. For this, a Cognitive Bias Modification (CBM) eHealth app (IVY) has been developed.

View Article and Find Full Text PDF

Purpose: To clarify the implementation steps, characteristics, effects, acceptability, and feasibility of the stepped care model (SCM) while also offering a resource for pertinent interventions in cancer care.

Methods: We searched the PubMed, Embase, CINAHL, Web of Science, the Cochrane Library, and PsycINFO databases from inception to October 22, 2023. Two key concepts were used: cancer and stepped care model.

View Article and Find Full Text PDF

Objective: To study the effects of Changtong Paste on gastrointestinal function after colorectal cancer surgery.

Methods: A retrospective analysis was conducted on the clinical data of 216 patients who underwent colorectal cancer surgery at the Affiliated Hospital of North Sichuan Medical College from June 2021 to June 2023. Patients were divided into two groups according to their treatment plan: the control group (n=109), who received abdominal multi-source therapy irradiation, and the study group (n=107), who received Changtong Paste in conjunction with the same abdominal irradiation therapy.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!